The flare-up of Judy Hays’ leukemia in March followed a familiar pattern in nine years of fighting the disease — medicines working for a while, then not working.
Fortunately for the retired office manager, her doctor at UPMC Hillman Cancer Center in Shadyside found a new drug to try. It worked, easing her night sweats, fatigue and nausea.
Now, the challenges of her treatment are being complicated by rules rather than medical decisions.
After June 30, Ms. Hays, who has Highmark health insurance, can no longer go to the cancer treatment center where doctors brought her most recent flare-up under control. That’s when Highmark and UPMC — barring a state Supreme Court ruling otherwise — break off contractual relations for good.
Ms. Hays has been the public face of Attorney General Josh Shapiro’s challenge to UPMC’s refusal to sign a contract with rival Highmark. Mr. Shapiro wants patients to have the choice of seeing UPMC doctors indefinitely, regardless of their health insurance coverage.
“My cancer is not curable, but it’s treatable,” Ms. Hays said. “Some forms of treatment do not work, and I’ve had that happen.”
Read More
Her anxiety over her care is shared by other Highmark members who will have to stop seeing doctors at the Hillman center in two months because they will be out of network and therefore the fees will be prohibitively expensive.
As with much of this battle over health care and insurance, the split isn’t as simple as it might appear.

Even though Highmark members will soon be barred from UPMC’s cancer center, they will be able to continue seeing UPMC doctors in network at a dozen cancer treatment centers connected to the Pittsburgh health giant. Several of the centers are operated as 50-50 joint ventures with independent community hospitals.
Ms. Hays’ last appointment at UPMC Hillman is June 17. At that point, she will return for treatment at UPMC Cancer Center Sewickley — a partnership between UPMC and Heritage Valley Sewickley Hospital, where she started treatment years ago.
Some community hospitals have “lease” agreements with UPMC doctors, which allow patients to receive one bill from the hospital rather than a second bill from UPMC for cancer care, said Tom Fitzpatrick, senior vice president, provider contracting and relations at Highmark.
UPMC Hillman-St. Clair Hospital Cancer Center is among the joint venture centers that will be issuing one bill for care.
“Those doctors will remain on an in-network basis to Highmark members,” Mr. Fitzpatrick said. “We’re doing everything we can to assure members can have access to care that is uninterrupted.”
Mr. Fitzpatrick said 1,500 Highmark commercial health insurance members have been treated at the UPMC joint venture centers, with 66 patients treated at both the community hospital clinics and at UPMC Hillman in Shadyside between January and August 2018.
For second medical opinions or treatment for more complex cases, Highmark members have access to the Allegheny Health Network Cancer Institute, which has partnered with the Johns Hopkins Kimmel Cancer Center in Baltimore.
AHN is also building six community cancer treatment centers as part of a $225 million expansion of its footprint.
“It’s highly unlikely patients would ever have to leave Pittsburgh,” said Allegheny Health Network Cancer Institute Chair Dave Parda. “In 99.99 percent of the cases, everything’s covered. And when it isn’t, there’s consultation with Hopkins, which is pretty much embedded into our processes.”
And even though UPMC and Highmark compete for patients, cancer services sometimes overlap: Ms. Hays’ oncologist at UPMC Hillman, James Rossetti, for example, trained at AHN, Dr. Parda added.
Meanwhile, UPMC has more than 200 medical, radiation and surgical cancer doctors at more than 60 locations in Western Pennsylvania and Ohio. Each center is closely tied to UPMC Hillman in Shadyside, so the care is consistent, regardless of where it’s provided, a spokeswoman said.
Most recently, UPMC Hillman doctors prescribed maintenance infusions of Rituxan for Ms. Hays, an immunotherapy drug approved by the Food and Drug Administration in 1997 for non-Hodgkin’s lymphoma. Since then, it has been prescribed for an expanding number of other diseases, including chronic lymphocytic leukemia.
“It’s working,” Ms. Hays said. “You take it until the disease starts to progress, then hopefully there’s something else out there. So, we’ll see how long it keeps the disease from progressing.”
She keeps her mind off cancer by staying involved in a variety of activities, including singing in her church choir, gardening and caring for her 76-year-old husband, David, a retired school principal who has had multiple sclerosis for 25 years.
If her disease stops responding to the current treatment, she has a plan for the not-too-distant future.
She said she will switch health insurance coverage in January 2020 to a carrier that offers access to both AHN and UPMC doctors. That will allow her to return to UPMC Hillman, if needed, while her husband can continue seeing his Allegheny Health Network doctors.
“My numbers are almost normal,” the 75-year-old Ms. Hays said about her latest blood-cell count, adding that she was optimistic about the new medicine she’s taking.
“And hopefully, it’ll give me a couple more years. That’s how we do it.”
Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699.






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.